Piotech (SH:688072) Xin Lang Cai Jing·2025-12-29 14:01Core Viewpoint - The company has optimized its non-capital expenditures significantly in its fundraising projects, aligning with regulatory requirements and focusing on high-end semiconductor equipment and technology development [1][2][3]. Group 1: Fundraising and Expenditure - The company plans to raise up to 4.6 billion yuan, with allocations of 1.5 billion yuan for high-end semiconductor equipment industrialization, 2 billion yuan for advanced technology research center, and 1.1 billion yuan for working capital [3]. - The non-capital expenditures in the current fundraising plan account for 38.94% of the total, with 1.7 billion yuan specifically allocated for the advanced technology research center [3]. - The previous non-capital expenditure ratio was reduced from 77.22% to 29.78% after adjustments in project funding allocations [2]. Group 2: Research and Development Capitalization - The company’s R&D capitalization rate is projected at 51.33%, which is in line with industry standards and similar to peers like Zhongwei Company [4]. - The company capitalizes R&D expenditures at specific project milestones, ensuring compliance with accounting standards [4]. Group 3: Financial Health and Performance - The company has a projected total funding gap of approximately 7.454 billion yuan from 2025 to 2027, with a current asset-liability ratio of 67.72% [5]. - Revenue is expected to grow from 1.706 billion yuan in 2022 to 4.103 billion yuan in 2024, reflecting a compound annual growth rate of 55.08% [6]. - As of September 2025, the company reported a significant improvement in cash flow, with net cash flow from operating activities reaching 2.832 billion yuan [7].